Today's top medical abstracts
Nephrology
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?

Home
General Nephrology
Messages
Conferences
Jobs
Newsletters
My Library
Topics in
Nephrology
        Acid-Base
        Basic Science/Genetics
        Chronic Dz/Renal Failure
        Cystic Dz
        Dialysis
        Economics of Medicine
        Endocrinology
        Fluids and Electrolytes
        Glomerular/Tubular Dz
        Hematology/Oncology
        Hypertension
        Nephropathies
        Pediatric Nephrology
        Pharmacology/kinetics
        Popular Press
        Radiology/Diagnostics
        Stone Disease
        Transplantation
        Ureteral Disease
        Vascular
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor

Renal Cell Carcinoma Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website
Risk factors for ipsilateral adrenal involvement in renal cell carcinoma
Urology, 06/23/08
Print     Email This Article     Save in My Library   Free Abstract
Ito K et al. - Tumor size >5.5 cm, clinical T stage of ≥3, LNM, and DM outside IAd are important preoperative indicators of ipsilateral adrenal involvement (IADI). Moreover, patients with renal cell carcinoma (RCC) who have normal adrenal, a T1 tumor extending <5.5 cm, and have neither lymph node metastasis (LNM) nor distant metastasis (DM) are good candidates for adrenal-sparing nephrectomy.

Methods
  • A retrospectively review of pts treated for RCC to clarify the risk factors for IADI
  • Clinicopathologic factors of 30 pts with IADI were compared with 926 control pts w/o IADI
  • Independent predictors for IADI were identified by multivariate analysis

Results
  • Preoperative CT scan could detect 83.3% of synchronous ipsilateral adrenal metastasis
  • Pts with IADI had larger primary tumors, higher pT stages and histologic grades, and higher percentages of upper pole involvement, microvascular invasion, spindle-cell-type tumors, LNM and DM outside the IAd vs control pts
  • Tumor size >5.5 cm, pT stage ≥3, LNM, and DM outside IAd, but not upper pole involvement, were significant predictors of IADI

 

Sponsor
--- HEMATOLOGY/ONCOLOGY TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email



Sponsor
Read a Different Specialty
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology
Profession Index
Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2008 MDLinx, Inc.